Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-036422
Filing Date
2023-06-12
Accepted
2023-06-12 17:38:02
Documents
1
Period of Report
2023-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5858
  Complete submission text file 0001209191-23-036422.txt   7313
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Issuer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEUROCRINE BIOSCIENCES, INC. 12780 EL CAMINO REAL SAN DIEO CA 92130
Business Address
ROBERTS EIRY (Reporting) CIK: 0001727606 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33497 | Film No.: 231009498